1 Recommendation

1 Recommendation

1.1 There is currently insufficient evidence to recommend the routine adoption in the NHS of the LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi. The tests show promise and further research to provide robust evidence is encouraged, particularly to demonstrate the value of using the test results in clinical decision‑making (see sections 5.18 to 5.22).

  • National Institute for Health and Care Excellence (NICE)